AR109364A1 - ANTIVIRAL COMPOUNDS - Google Patents
ANTIVIRAL COMPOUNDSInfo
- Publication number
- AR109364A1 AR109364A1 ARP170102299A ARP170102299A AR109364A1 AR 109364 A1 AR109364 A1 AR 109364A1 AR P170102299 A ARP170102299 A AR P170102299A AR P170102299 A ARP170102299 A AR P170102299A AR 109364 A1 AR109364 A1 AR 109364A1
- Authority
- AR
- Argentina
- Prior art keywords
- antiviral compounds
- compound
- formula
- useful
- pharmaceutically acceptable
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 230000000840 anti-viral effect Effects 0.000 title 1
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 1
- 241000712907 Retroviridae Species 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente descripción se refiere a un compuesto de fórmula (1), (2), (3) y (4), que son útiles en el tratamiento de una infección viral por Retroviridae incluyendo una infección causada por el virus del VIH. Reivindicación 1: Un compuesto de fórmula (1) o una sal farmacéuticamente aceptable del mismo.The present description refers to a compound of formula (1), (2), (3) and (4), which are useful in the treatment of a viral infection by Retroviridae including an infection caused by the HIV virus. Claim 1: A compound of formula (1) or a pharmaceutically acceptable salt thereof.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662377312P | 2016-08-19 | 2016-08-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR109364A1 true AR109364A1 (en) | 2018-11-21 |
Family
ID=64499920
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170102299A AR109364A1 (en) | 2016-08-19 | 2017-08-17 | ANTIVIRAL COMPOUNDS |
| ARP190102131A AR115865A2 (en) | 2016-08-19 | 2019-07-29 | THERAPEUTIC COMPOUNDS |
| ARP190103689A AR117709A2 (en) | 2016-08-19 | 2019-12-16 | PHARMACEUTICAL COMPOSITION INCLUDING A SUBSTITUTED 1H-INDAZOLE COMPOUND, SAID COMPOUND AND PARENTERAL FORMULATION OF THE SAME |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP190102131A AR115865A2 (en) | 2016-08-19 | 2019-07-29 | THERAPEUTIC COMPOUNDS |
| ARP190103689A AR117709A2 (en) | 2016-08-19 | 2019-12-16 | PHARMACEUTICAL COMPOSITION INCLUDING A SUBSTITUTED 1H-INDAZOLE COMPOUND, SAID COMPOUND AND PARENTERAL FORMULATION OF THE SAME |
Country Status (2)
| Country | Link |
|---|---|
| AR (3) | AR109364A1 (en) |
| HR (1) | HRP20191601T1 (en) |
-
2017
- 2017-08-17 AR ARP170102299A patent/AR109364A1/en not_active Application Discontinuation
-
2019
- 2019-07-29 AR ARP190102131A patent/AR115865A2/en not_active Application Discontinuation
- 2019-09-04 HR HRP20191601 patent/HRP20191601T1/en unknown
- 2019-12-16 AR ARP190103689A patent/AR117709A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR117709A2 (en) | 2021-08-25 |
| HRP20191601T1 (en) | 2019-11-29 |
| AR115865A2 (en) | 2021-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2019000033A (en) | THERAPEUTIC COMPOUNDS | |
| CL2018002528A1 (en) | Anti viral agents of hepatitis b. | |
| DOP2021000147A (en) | THERAPEUTIC COMBINATION COMPRISING LAMIVUDINE | |
| CY1123570T1 (en) | HEPATITIS B NUCLEAR PROTEIN MODIFIERS | |
| UY37997A (en) | ANTIVIRAL AGENTS AGAINST HEPATITIS B | |
| CU20150096A7 (en) | AMIDA COMPOUNDS AND PHARMACEUTICAL COMPOSITION FOR HIV TREATMENT | |
| MX2022012616A (en) | ATAZANAVIR ANALOGS (ATV) TO TREAT HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTIONS. | |
| CL2020000886A1 (en) | 1-Benzyl-2-imino-4-phenyl-5-oxoimidazolidine derivatives as hiv protease inhibitors. | |
| CO2019000069A2 (en) | Antiviral agents against hepatitis b | |
| CL2020000487A1 (en) | Antiviral agents against hepatitis b. | |
| UY37998A (en) | ANTIVIRAL AGENTS AGAINST HEPATITIS B | |
| UY38483A (en) | HETEROCYCLES FUNCTIONALIZED AS ANTIVIRAL AGENTS | |
| CO2018009382A2 (en) | Elimination of hepatitis B virus with antiviral agents | |
| UY35263A (en) | THERAPEUTIC COMPOUNDS | |
| CO2017007355A2 (en) | Compounds derived from pyrazinecarbozamide and pyrazinecarboxylate for the treatment of hepatitis b virus infection | |
| EA201791872A1 (en) | POLYCYCLIC CARBAMOILPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL APPLICATIONS | |
| EA201791019A1 (en) | POLYCYCLIC CARBAMOILPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL APPLICATIONS | |
| CU24525B1 (en) | QUINOLEIN DERIVATIVE TO TREAT AND PREVENT VIRAL INFECTIONS | |
| AR099632A1 (en) | TREATMENT OF A VIRAL INFECTION OF HEPATITIS C, THAT USES A COMBINATION OF COMPOUNDS | |
| UY38383A (en) | HETEROCYCLES FUNCTIONALIZED AS ANTIVIRAL AGENTS | |
| CL2017000714A1 (en) | Long-acting pharmaceutical compositions | |
| AR109364A1 (en) | ANTIVIRAL COMPOUNDS | |
| AR111017A1 (en) | HEMISULFATE SALT OF A NUCLEOTID COMPOUND FOR THE TREATMENT OF HEPATITIS C VIRUS | |
| EA201990295A1 (en) | THERAPEUTIC COMPOUNDS THAT CAN BE USED FOR PREVENTIVE OR THERAPEUTIC TREATMENT OF HIV VIRUS INFECTION | |
| EA202092602A2 (en) | -D-2'-DESOXY-2 '- FLUORINE-2' - C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR THE TREATMENT OF HCV-INDUCED DISEASES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |